학술논문

Characteristics and prognosis of distant metastasis after primary treatment for early‐stage extranodal nasal‐type natural killer/T‐cell lymphoma from the China Lymphoma Collaborative Group database
Document Type
Report
Source
ejHaem. February 2023, Vol. 4 Issue 1, p78, 12 p.
Subject
Development and progression
Prognosis
Non-Hodgkin lymphomas -- Prognosis -- Development and progression
Chemotherapy
Skin
Cancer metastasis -- Prognosis -- Development and progression
Risk assessment
T cells
Metastasis -- Prognosis -- Development and progression
Non-Hodgkin's lymphomas -- Prognosis -- Development and progression
Cancer -- Chemotherapy
Language
English
Abstract
INTRODUCTION Extranodal nasal‐type natural killer (NK)/T‐cell lymphoma (ENKTCL) is rare globally but is relatively common in East Asia and South America [1–3]. The disease usually originates from the upper aerodigestive [...]
: This study aimed to investigate the characteristics and prognosis of distant metastasis (DM) after primary treatment for early‐stage extranodal nasal‐type natural killer (NK)/T‐cell lymphoma (ENKTCL). A total of 1619 patients from the China Lymphoma Collaborative Group database were retrospectively reviewed. The cumulative incidence of DM was assessed using Fine and Gray's competing risk analysis. The correlation between DM sites was evaluated using phi coefficients, while DM sites were classified using hierarchical clustering. Regression analysis was used to assess the linear correlation between DM‐free survival (DMFS) and overall survival (OS). The 5‐year cumulative DM rate was 26.2%, with the highest annual hazard rate being in the first year (14.9%). The most frequent DM sites were the skin and soft tissues (SSTs, 32.4%) and distant lymph nodes (LNs, 31.3%). DM sites were categorized into four subgroups of distinct prognosis — distant LN, SST, extracutaneous site, and lymphoma‐associated hemophagocytic lymphohistiocytosis. SST or distant LN, solitary metastasis, and late‐onset DM demonstrated a relatively favorable prognosis. Contemporary chemotherapy significantly decreased DM rates and improved DMFS. Decreased DM rates were further associated with increased OS probabilities. Our findings improve the understanding of the variable clinical behaviors of early‐stage ENKTCL based on four distinct DM sites and thus provide guidance for future therapeutic decisions, metastatic surveillance, and translational trial design.